ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Ohio » Neuromusculoskeletal Medicine OMM

Top Neuromusculoskeletal Medicine OMM Prescribers in Ohio

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
THEODORE CUBBISON DO

Neuromusculoskeletal Medicine OMM

15,986

$1.12M

485
285 are 65+

8%
patients receiving schedule two controlled substances

Avg: 31%

13%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

27%
prescriptions for brand name drugs

Avg: 24%

$70
Average prescription price

Avg: $83

VINCENT MALKOVITS D.O.

Neuromusculoskeletal Medicine OMM

10,585

$680K

424
299 are 65+

7%
patients receiving schedule two controlled substances

Avg: 31%

17%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

27%
prescriptions for brand name drugs

Avg: 24%

$64
Average prescription price

Avg: $83

KEVIN REID DO

Neuromusculoskeletal Medicine OMM

9,274

$626K

1050
804 are 65+

1%
patients receiving schedule two controlled substances

Avg: 31%

3%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

23%
prescriptions for brand name drugs

Avg: 24%

$68
Average prescription price

Avg: $83

GLENN BLANKENHORN DO

Neuromusculoskeletal Medicine OMM

3,051

$419K

148
28 are 65+

87%
patients receiving schedule two controlled substances

Avg: 31%

21%
patients receiving schedule three controlled substances

Avg: 10%

12%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

23%
prescriptions for brand name drugs

Avg: 24%

$137
Average prescription price

Avg: $83

ANDREAS SYLLABA DO

Neuromusculoskeletal Medicine OMM

2,712

$353K

443
85 are 65+

79%
patients receiving schedule two controlled substances

Avg: 31%

19%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

29%
prescriptions for brand name drugs

Avg: 24%

$130
Average prescription price

Avg: $83

JOSEPH ZAYAT MD

Neuromusculoskeletal Medicine OMM

2,075

$214K

305
247 are 65+

0%
patients receiving schedule two controlled substances

Avg: 31%

0%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

20%
prescriptions for brand name drugs

Avg: 24%

$103
Average prescription price

Avg: $83

AMARJEET NAGPAUL M.D

Neuromusculoskeletal Medicine OMM

528

$242K

55
38 are 65+

0%
patients receiving schedule two controlled substances

Avg: 31%

0%
patients receiving schedule three controlled substances

Avg: 10%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

33%
prescriptions for brand name drugs

Avg: 24%

$458
Average prescription price

Avg: $83

STEPHEN POPPER D.O.

Neuromusculoskeletal Medicine OMM

494

$74.1K

55
17 are 65+

42%
patients receiving schedule two controlled substances

Avg: 31%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

23%
prescriptions for brand name drugs

Avg: 24%

$150
Average prescription price

Avg: $83

PAUL SCHEATZLE DO

Neuromusculoskeletal Medicine OMM

447

$27.6K

88
50 are 65+

38%
patients receiving schedule two controlled substances

Avg: 31%

15%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

24%
prescriptions for brand name drugs

Avg: 24%

$62
Average prescription price

Avg: $83

JUDITH O'CONNELL D.O.

Neuromusculoskeletal Medicine OMM

411

$33.9K

61
47 are 65+

23%
patients receiving schedule two controlled substances

Avg: 31%

25%
patients receiving schedule three controlled substances

Avg: 10%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

16%
prescriptions for brand name drugs

Avg: 24%

$83
Average prescription price

Avg: $83

JAMES LAUB D.O.

Neuromusculoskeletal Medicine OMM

263

$21.8K

26
12 are 65+

54%
patients receiving schedule two controlled substances

Avg: 31%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

23%
prescriptions for brand name drugs

Avg: 24%

$83
Average prescription price

Avg: $83

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank